Press "Enter" to skip to content

Cancer Blame Game; New Smoker, Same Lung Effects; Another HPV Cancer?

Patients need to know that cancer is not their fault. (ASCO Connection)

Since 1990, about half a million fewer breast cancer deaths occurred than would have been expected at that time, credited to early detection with mammography and improved treatment. (Cancer)

Another new smoking device, the same old effects on the lungs. (European Respiratory Journal)

A young female oncologist recounts the evolution of her professional relationship with a dubious older patient. (Journal of Clinical Oncology)

Many people at high risk for colon cancer aren’t taking aspirin for prevention. (Florida Atlantic University, American Journal of Medicine)

The black-white disparity in cancer deaths has almost disappeared in some age groups. (American Cancer Society)

Human papillomavirus (HPV) on the hands is unlikely to spread to other people. (McGill University, Lancet Infectious Disease)

HPV infection might be the culprit in a recent increase in vocal-cord tumors in younger people. (Massachusetts General Hospital, Annals of Otology, Rhinology and Laryngology)

A study of middle-age women showed little awareness of the association between alcohol consumption and breast cancer. (PLOS ONE, Flinders University)

A new review suggested that exposure to glyphosate-containing weedkillers — at the center of multiple lawsuits related to the popular herbicide RoundUp — increases the risk of non-Hodgkin’s lymphoma by 41%. (The Guardian, Mutation Research/Reviews in Mutation Research)

New data seemed to refute evidence that exposure to phthalates (chemicals found in many household products) increases the risk of breast cancer. (UMass Amherst, Journal of the National Cancer Institute)

A type of artificial intelligence showed promise for predicting which breast lesions would progress to breast cancer, which could help many woman avoid unnecessary surgery. (JCO Clinical Cancer Informatics, Dartmouth Hitchcock Medical Center)

A favorable review of a new type of cancer drug that demonstrated activity in patients with heavily treated cancers. (GlobalData)